🔎 Trials Near Me

Utama › Obesiti › Texas › Amarillo

Kajian klinikal Obesiti di Amarillo, TX

10 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar Amarillo (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 2
  • Amarillo Medical Specialists /ID# 282380, Amarillo
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Mengambil pesertaFasa 3
  • Amarillo Medical Specialists, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Mengambil pesertaFasa 3
  • Amarillo Med Spec LLP, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Mengambil pesertaFasa 3
  • Amarillo Medical Specialists, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07339423

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • PharmaTex Research, LLC, Amarillo
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • PharmaTex Research, LLC, Amarillo
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284875

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mengambil pesertaFasa 3
  • PharmaTex Research, LLC, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Mengambil pesertaFasa 1
  • Amarillo Medical Specialists, Amarillo
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT07607587

Kajian Obesiti di bandar lain

Kajian lain di Amarillo

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.